Targeting β-catenin in acute myeloid leukaemia: past, present, and future perspectives

Acute myeloid leukaemia (AML) is an aggressive disease of the bone marrow with a poor prognosis. Evidence suggests long established chemotherapeutic regimens used to treat AML are reaching the limits of their efficacy, necessitating the urgent development of novel targeted therapies. Canonical Wnt s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagstaff, Megan, Coke, Brandon, Hodgkiss, Georgia R., Morgan, Rhys G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2022
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069440/
https://www.ncbi.nlm.nih.gov/pubmed/35352805
http://dx.doi.org/10.1042/BSR20211841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069440/
https://www.ncbi.nlm.nih.gov/pubmed/35352805
http://dx.doi.org/10.1042/BSR20211841

Ejemplares similares